(Page 2 of 2)
to $575 million for global rights to its experimental drug for endometriosis.
—Bryan Roberts, a Venrock partner in San Francisco who oversees the firm’s life sciences and health IT investments, told a San Diego audience that the healthcare industry is projected to spend only a fourth as much as the financial services industry on new IT infrastructure.
—The West Wireless Health Institute announced it will collaborate with the Carlos Slim Health Institute in Mexico City to advance wireless health solutions in the United States, Mexico, and Latin America. The institute also forged technology and education partnerships with CareFusion (NYSE: CFN), Cisco Systems (NASDAQ: CSCO), and Medtronic (NYSE: MDT).
—San Diego’s Cadence Pharmaceuticals (NASDAQ: [[ticker:CADX CADX), which has been developing an intravenous form of acetaminophen for pain relief in hospitals, said it got an exclusive option to acquire Incline Therapeutics of Redwood City, CA.
—The Michael J. Fox Foundation for Parkinson’s Research gave San Diego’s Ceregene $2.5 million to help fund a mid-stage gene therapy study that aims to deliver the neurotrophic factor neurturin to improve the status of degenerating neurons in the brain.
—Existing investors committed as much as $20 million to San Diego’s Nereus Pharmaceuticals needed to fund a mid-stage trial of a drug candidate for treating non-small cell lung cancer. The company specializes in developing drugs from marine microbes.